Journal Article Summary
The article focuses on the treatment of metastatic castration-resistant prostate cancer (mCRPC) in black men, a group that experiences higher rates of incidence and mortality from prostate cancer compared to white men. Despite this, black men are significantly underrepresented in clinical trials for new therapies. The study aimed to explore the effectiveness and safety of abiraterone acetate combined with prednisone in this population, while also investigating the genetic factors that might influence treatment response.
In this phase II trial, 11 black men with mCRPC were treated with abiraterone acetate and prednisone. The primary goal was to assess whether there was a significant reduction in prostate-specific antigen (PSA) levels, which would indicate antitumor activity. Results showed that 90% of the evaluable patients experienced a decline in PSA levels of 30% or more, and the treatment was generally well tolerated. However, the study was cut short due to low enrollment, which limited the ability to conduct further genetic analyses as initially planned.
The study has some limitations, particularly the small sample size and the premature termination, which hindered comprehensive analysis. This highlights ongoing challenges in enrolling black men in clinical trials, which may stem from various factors, including perceived ineligibility and reluctance to participate. Patients and caregivers should discuss these findings and any concerns about treatment options with healthcare professionals, especially considering the importance of representation in clinical research for better understanding and addressing health disparities.
Medical Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Tsao Che-Kai, Sfakianos John, Liaw Bobby, Gimpel-Tetra Kiev, Kemeny Margaret, Bulone Linda, Shahin Mohammad, Oh William Kyu, et al.. Phase II Trial of Abiraterone Acetate Plus Prednisone in Black Men With Metastatic Prostate Cancer. The Oncologist 2016. DOI: 10.1634/theoncologist.2016-0026. PMID: 27742908. PMCID: PMC5153336.
Featured Pill Pals Product
Prednisone 1 mg Tablets --- Generic For Deltasone --- Aurobindo
Prednisone 1 mg Tablets — Generic For Deltasone — Aurobindo is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
